Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTrufin Plc Regulatory News (TRU)

Share Price Information for Trufin Plc (TRU)

Share Price is delayed by 15 minutes
Get Live Data
134.00    0.00 (0.00%)
Bid:
133.00
Ask:
135.00
Spread: 2.00 (1.504%)
Market Cap: £126.23m
TRU Live PriceLast checked at - London Stock Exchange

Intraday Trufin Plc Share Chart

Trading Statement

18 Nov 2024 07:00

RNS Number : 5566M
TruFin PLC
18 November 2024
 

18 November 2024

TruFin plc("TruFin" or the "Company" or together with its subsidiaries the "Group")

Trading & Outlook Update

 

TruFin is pleased to announce that it expects revenues for the 12 months ending 31 December 2024 to be significantly ahead of market expectations at more than £42m (FY23: £18.1m), representing year-on-year growth in excess of 132%. This has predominately been driven by a strong performance from the console and mobile divisions of Playstack Ltd ("Playstack").

As a result the Group is on track to record its first year of positive EBITDA, at no less than £3.5m (FY23: £(3.5)m), materially ahead of market expectations. Despite absorbing the financial impact from the termination of a Tier-1 Bank's contract at Satago Financial Solutions Limited ("Satago"), the Group's Adjusted Loss Before Tax ("LBT") is also anticipated to show a material improvement year on year at a loss of no more than £(2.5)m (FY23: £(6.6)m).

The Group's cash position is also stronger than originally expected, with unrestricted cash or cash equivalents of no less than £10m as at 31 October 2024.

2024 has been a transformational year for the Group. Playstack and Oxygen Finance Group Limited ("Oxygen") are now profitable, and both remain on track to grow significantly over the coming years.

Playstack's proprietary discovery technology, Magnitude, continues to identify games which deliver exceptional returns on invested capital. Following this year's highly successful launches of Balatro, Abiotic Factor and Rise of the Golden Idol, Playstack has already secured an exciting lineup of 10 games for release in 2025 and 2026.

Oxygen has once again performed consistently and predictably. With its large, embedded client base and significant operational leverage, the Board expects Oxygen's EBITDA to continue to grow at highly attractive rates during 2025 and beyond.

Medium Term Outlook

Given the Group's performance, strong cash position and increasing visibility, the Board is pleased to present its medium-term financial guidance. Given the outstanding success of 2024, the Board expects 2025 to see a consolidation of the record revenue outcome in 2024. Importantly, the Board expects Group EBITDA to remain on a sustainably positive trajectory during 2025 and beyond. The Group also expects to record its first annual Profit Before Tax ("PBT") in 2025, as the benefits of meaningful cost realignment at Satago take effect.

2026 is expected to see significant top line growth, whilst EBITDA and PBT are anticipated to grow materially as the Group benefits from the inherent operating leverage within the businesses. As a result, the Board expects 2026 revenues for the Group to be more than £55m with an expected Group EBITDA margin of no less than 20%.

The Board continually appraises the capital requirements of the Group and always looks to deploy excess capital as efficiently as possible, including consideration as to whether excess capital should be returned to shareholders.

As Oxygen and Playstack continue to scale they are becoming increasingly attractive to financial and strategic acquirers. The Board remains fully committed to maximising value for shareholders and will continue to evaluate all opportunities.

 

The information contained within this Announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No.596/2014 as amended by The Market Abuse (Amendment) (EU Exit) Regulations 2019. By the publication of this Announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain. The person responsible for arranging for the release of this Announcement on behalf of the Company is Annie Styler.

 

For further information, please contact:

TruFin plcJames van den Bergh, Chief Executive OfficerKam Bansil, Investor Relations

0203 743 134007779 229508

Panmure Liberum Limited (Nominated Adviser and Corporate broker)Chris ClarkeEdward Thomas

0203 100 2000

 

 

TruFin plc is the holding company of an operating group comprising three growth-focused technology businesses operating in niche markets: early payment provision, invoice finance and mobile games publishing. The Company was admitted to AIM in February 2018 and trades under the ticker symbol: TRU. More information is available on the Company website: www.TruFin.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTDZMMMNNFGDZM
Date   Source Headline
20th Dec 20239:40 amRNSHolding(s) in Company
14th Dec 20237:00 amRNSAppointment of INED to the Board of Oxygen
21st Nov 20237:00 amRNSPlaystack enters into LoI for sale of Interact
9th Nov 20237:00 amRNSOxygen Finance acquisition of bidstats.uk
18th Oct 20234:19 pmRNSHolding(s) in Company
5th Oct 20237:00 amRNSSale of Majority Holding in Vertus
29th Sep 20237:00 amRNSHalf-year Report
28th Sep 202312:07 pmRNSResult of AGM
14th Sep 20238:00 amRNSPlaystack releases award-winning game - AK-xolotl
29th Aug 20236:19 pmRNSNotice of AGM
21st Aug 20237:00 amRNSNon-Binding Offer for Vertus
28th Jul 20237:00 amRNSGrant of Share Awards under LTIP
18th Jul 20238:59 amRNSHolding(s) in Company
18th Jul 20238:58 amRNSHolding(s) in Company
18th Jul 20238:55 amRNSHolding(s) in Company
10th Jul 202312:03 pmRNSResult of GM and Result of Placing and Open Offer
23rd Jun 20237:00 amRNSResult of Placing and Notice of General Meeting
22nd Jun 20234:45 pmRNSProposed Placing and Open Offer
18th May 20233:04 pmRNSHolding(s) in Company
26th Apr 20237:00 amRNSOxygen Finance secures six Early Payment contracts
15th Mar 20237:00 amRNSFinal Results for the year ended 31 December 2022
28th Feb 20235:43 pmRNSHolding(s) in Company
23rd Jan 20237:00 amRNSStatement re Satago
20th Jan 20237:00 amRNSStatement regarding Satago and Trading Update
22nd Dec 20227:00 amRNSRejected Indicative Offer for Oxygen
15th Nov 20227:00 amRNSOxygen surpasses £1b in early payment provision
3rd Nov 20227:00 amRNSPlaystack releases new console game
20th Oct 20227:00 amRNSSatago signs agreement with Sage
10th Oct 20227:00 amRNSNotice of Capital Markets Day
30th Sep 20227:00 amRNSPDMR Notification
20th Sep 20227:00 amRNSInterim Results
12th Sep 20227:00 amRNSNotice of Capital Markets Day
25th Aug 20229:37 amRNSHolding(s) in Company
29th Jul 20229:00 amRNSPrice Monitoring Extension
29th Jul 20227:00 amRNSSatago signs commercial agreement with Lloyds
1st Jul 20227:00 amRNSHolding(s) in Company
9th Jun 20227:00 amRNSSatago partnership with Sage and Lloyds
7th Jun 202211:19 amRNSResult of AGM
6th Jun 20227:00 amRNSStatement re Playstack
4th May 20225:58 pmRNSNotice of AGM
29th Apr 20227:00 amRNSFinal Results For The Year Ended 31 December 2021
19th Apr 202212:04 pmRNSHolding(s) in Company
12th Apr 20225:53 pmRNSHolding(s) in Company
11th Apr 202210:18 amRNSResult of GM and Result of Placing and Open Offer
23rd Mar 20227:00 amRNSResult of Placing and Notice of General Meeting
22nd Mar 20224:51 pmRNSProposed Placing and Open Offer
9th Mar 20227:00 amRNSStatement re Satago
22nd Feb 20222:04 pmRNSVesting of JSOP Founder Awards
16th Feb 20227:00 amRNSDirectorate Change and Relationship Agreement
10th Dec 20217:00 amRNSStatement regarding Satago and Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.